88P Hepatic arterial infusion chemotherapy (HAIC) + lenvatinib (len) and tislelizumab (tis) ± transhepatic arterial embolization (TAE) for unresectable hepatocellular carcinoma (uHCC) with portal vein tumor thrombus (PVTT) and high tumor-burden: A multicenter retrospective study. (December 2022) - Guo, W.; Chen, S.